Jubilant Ingrevia Ltd is Rated Strong Sell

Feb 17 2026 10:10 AM IST
share
Share Via
Jubilant Ingrevia Ltd is rated Strong Sell by MarketsMojo, with this rating last updated on 05 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 17 February 2026, providing investors with the latest insights into the company’s performance and outlook.
Jubilant Ingrevia Ltd is Rated Strong Sell

Understanding the Current Rating

The Strong Sell rating assigned to Jubilant Ingrevia Ltd indicates a cautious stance for investors, suggesting that the stock is expected to underperform relative to the broader market. This rating is derived from a comprehensive evaluation of four key parameters: Quality, Valuation, Financial Trend, and Technicals. Each of these factors contributes to the overall assessment of the company’s investment potential.

Quality Assessment

As of 17 February 2026, Jubilant Ingrevia’s quality grade is classified as average. This reflects moderate operational efficiency and business fundamentals. Over the past five years, the company has experienced a decline in net sales, with an annualised growth rate of -0.45%, signalling challenges in expanding its revenue base. Operating profit has also contracted significantly at an annual rate of -13.67%, indicating pressure on profitability. The quarterly profit after tax (PAT) stands at ₹56.25 crores but has fallen by 21.9% compared to the previous four-quarter average, highlighting recent earnings weakness. Additionally, the debtors turnover ratio for the half-year is at a low 5.56 times, suggesting slower collection cycles which may impact liquidity.

Valuation Perspective

Despite the operational challenges, the valuation grade for Jubilant Ingrevia is currently attractive. This suggests that the stock is trading at a price level that may offer value relative to its earnings and asset base. Investors looking for potential bargains might find the current price appealing, especially given the company’s small-cap status within the specialty chemicals sector. However, valuation attractiveness alone does not offset the risks posed by deteriorating fundamentals and financial trends.

Financial Trend Analysis

The financial grade is negative, reflecting ongoing difficulties in the company’s financial health. Operating profit to interest coverage ratio for the latest quarter is at a low 10.16 times, indicating tighter margins for servicing debt. The company’s long-term growth trajectory remains weak, with declining sales and profitability metrics. These trends raise concerns about the sustainability of earnings and the ability to generate consistent shareholder returns.

Technical Indicators

From a technical standpoint, the stock is graded as bearish. The price performance over recent periods has been underwhelming, with the stock declining 9.00% over the past month and 11.21% over three months. Year-to-date, the stock has fallen 9.41%, and over the last six months, it has declined 9.08%. Although the one-year return is a modest -1.85%, this still underperforms the broader market benchmark, the BSE500, which has delivered a 13.31% return over the same period. The daily price movement on 17 February 2026 showed a modest gain of 1.61%, but this is insufficient to offset the prevailing downtrend.

Stock Returns and Market Comparison

As of 17 February 2026, Jubilant Ingrevia Ltd’s stock returns have lagged behind the market consistently. The one-week return is -3.37%, and the one-day gain of 1.61% is a minor positive blip amid a broader negative trend. The stock’s underperformance relative to the BSE500 index highlights the challenges faced by the company in regaining investor confidence and market momentum.

Implications for Investors

The Strong Sell rating signals that investors should exercise caution with Jubilant Ingrevia Ltd at this juncture. The combination of average quality, attractive valuation, negative financial trends, and bearish technicals suggests that the stock may face continued headwinds. Investors seeking capital preservation or growth may prefer to avoid exposure until there are clear signs of operational turnaround and financial improvement.

However, the attractive valuation could present an opportunity for value-focused investors who are willing to tolerate short-term volatility in anticipation of a potential recovery. It is essential to monitor upcoming quarterly results, debt servicing capacity, and any strategic initiatives that could improve the company’s fundamentals.

Fast mover alert! This Large Cap from Automobiles - Passeenger just qualified for our Momentum list with stellar technical indicators. Strike while the iron is hot!

  • - Recent Momentum qualifier
  • - Stellar technical indicators
  • - Large Cap fast mover

Strike Now - View Stock →

Company Profile and Sector Context

Jubilant Ingrevia Ltd operates within the specialty chemicals sector and is classified as a small-cap company. This sector is known for its cyclical nature and sensitivity to raw material prices and global demand fluctuations. The company’s current challenges in growth and profitability are reflective of broader sectoral pressures as well as company-specific operational issues.

Summary of Key Metrics as of 17 February 2026

The Mojo Score for Jubilant Ingrevia Ltd stands at 28.0, corresponding to a Strong Sell grade. This score has declined by 3 points from the previous 31, reflecting deteriorating fundamentals and technical outlook. The company’s operating profit and net sales have shown negative growth trends over the last five years, while recent quarterly PAT has declined sharply. The stock’s returns have underperformed the market benchmark significantly over the past year, reinforcing the cautious stance.

Investors should weigh these factors carefully when considering Jubilant Ingrevia Ltd for their portfolios. The current rating and analysis suggest that the stock is best suited for those with a high risk tolerance or a contrarian value approach, while more conservative investors may prefer to avoid exposure until clearer signs of recovery emerge.

Looking Ahead

Monitoring the company’s upcoming financial disclosures and market developments will be crucial. Improvements in sales growth, profitability, and debt servicing ratios could alter the investment outlook positively. Conversely, continued weakness in these areas may reinforce the current negative rating.

In conclusion, Jubilant Ingrevia Ltd’s Strong Sell rating as of 05 February 2026, combined with the latest data as of 17 February 2026, provides a comprehensive view of the stock’s current challenges and risks. Investors should remain vigilant and consider these factors carefully in their decision-making process.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News